Home › Calculator › SLS Dividend Calculator 2026
SLS Dividend DRIP Calculator 2026
18.12% YieldHealthcareSELLAS Life Sciences Group, Inc. · NASDAQ
Price: $11.04 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SLS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SLS snowball 📈
$10,000 in SLS → $375810.37M in 10 years · $31,149,615,249.79/month
About SELLAS Life Sciences Group, Inc. (SLS) — Dividend Analysis 2026
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Compare SLS with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SLS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SLS position with:
🌍 SLS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SLS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 18.12% | 15.32% | $1,812 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 15.40% | 12.60% | $1,540 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 14.50% | 11.70% | $1,450 / yr |
| 🇬🇧 UK ISA | 0% | 18.12% | 15.32% | $1,812 / yr |
| 🇬🇧 UK Taxable | 8.75% | 16.53% | 13.73% | $1,653 / yr |
| 🇨🇦 TFSA | 0% | 18.12% | 15.32% | $1,812 / yr |
| 🇨🇦 CA Taxable | 25% | 13.59% | 10.79% | $1,359 / yr |
| 🇦🇺 Super (pension) | 15% | 15.40% | 12.60% | $1,540 / yr |
| 🇦🇺 AU Taxable | 30% | 12.68% | 9.88% | $1,268 / yr |
| 🇩🇪 DE Taxable | 26.375% | 13.34% | 10.54% | $1,334 / yr |
| 🇫🇷 FR Taxable | 30% | 12.68% | 9.88% | $1,268 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SLS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SLS Dividend Payment Schedule
SLS pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SLS vs Healthcare Benchmarks
How SLS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SLS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SLS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-16 | 1,065,000 | — | — | ||
| A-Award | 2026-01-07 | 50,000 | — | — | ||
| A-Award | 2026-01-07 | 50,000 | — | — | ||
| A-Award | 2026-01-07 | 50,000 | — | — | ||
| A-Award | 2026-01-07 | 300,000 | — | — | ||
| A-Award | 2026-01-07 | 300,000 | — | — | ||
| A-Award | 2026-01-07 | 50,000 | — | — | ||
| A-Award | 2026-01-07 | 50,000 | — | — | ||
| J-Other | 2025-12-03 | 63,800 | $1.50 | $95.7K | ||
| J-Other | 2025-12-03 | 58,592 | $1.50 | $87.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SLS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
SELLAS Life Sciences Group, Inc. (SLS) is currently trading at $11.04, 17% below its 52-week high. The current dividend yield is 18.12% based on an annual payout of $2.00 per share.
SLS (SELLAS Life Sciences Group, Inc.) — 18.12% Dividend Yield Analysis
SELLAS Life Sciences Group, Inc. (SLS) is a healthcare stock currently trading at $11.04 with a dividend yield of 18.12%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (18.12%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.